Poster Author Of 2 e-Posters
93 - The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial
Presentation Number
93
Session Name
SESSION 29 - ORAL: Anticoagulation and Bleeding Complications in MCS Patients
Date
Thu, Apr 23, 2020
Time
02:00 PM - 03:45 PM
Authors
- O. Saeed, Bronx, NY, United States of America
- P. Columbo, New York, NY, United States of America
- M. Mehra, Pittsburgh, PA, United States of America
- N. Uriel, Bronx, NY, United States of America
- D. Goldstein, Bronx, NY, United States of America
- J. Cleveland, Colorado Springs, CO, United States of America
- J. Conners, Boston, MA, United States of America
- S. Najjar, Washington, DC, United States of America
- N. Mokadam, Columbus, OH, United States of America
- A. Bansal, New Orleans, LA, United States of America
- D. Crandall, Burlington, MA, United States of America
- P. Sood, Abbott Park, IL, United States of America
- U. Jorde, Bronx, NY, United States of America
96 - Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy
Presentation Number
96
Session Name
SESSION 29 - ORAL: Anticoagulation and Bleeding Complications in MCS Patients
Date
Thu, Apr 23, 2020
Time
02:00 PM - 03:45 PM
Authors
- U. Jorde, Bronx, NY, United States of America
- J. Katz, Chapel Hill, NC, United States of America
- P. Colombo, New York, NY, United States of America
- J. Stulak, Rochester, MN, United States of America
- D. Crandall, Burlington, MA, United States of America
- A. Franke, Sylmar, CA, United States of America
- R. Adamson, San Diego, CA, United States of America